Cornerstone Wealth Management’s Kazia Therapeutics KZIA Stock Holding History

Cornerstone Wealth Management’s Portfolio KZIA Stock Details KZIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-66	Closed	-$25K	–	293
2016 Q3	$25K	Buy	+66	New	+$25.7K	0.01%	272

Other funds holding KZIA

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Cornerstone Wealth Management's KZIA Position: Q4 2016 in Review

Cornerstone Wealth Management sold out of Kazia Therapeutics (KZIA) in Q4 2016, closing a stake of 66 shares — an estimated $25K sold.

Cornerstone Wealth Management first reported a position in KZIA in Q3 2016 and held it in 1 quarter. The position peaked at $25K in Q3 2016. 7 funds tracked by Wall St. Rank hold KZIA as of Q4 2016.

Cornerstone Wealth Management reported no remaining Kazia Therapeutics position as of Q4 2016 after selling out during the quarter.
Cornerstone Wealth Management sold 66 Kazia Therapeutics shares in Q4 2016, an estimated $25K.
Cornerstone Wealth Management first reported a position in Kazia Therapeutics in Q3 2016 and held it in 1 quarter.
Cornerstone Wealth Management's Kazia Therapeutics position peaked at $25K in Q3 2016.
7 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q4 2016.

Based on Cornerstone Wealth Management's 13F filing for Q4 2016, filed 14 Feb 2017.